MASS TORT AMERICA

CLIENT AGGREGATION SERVICES

MASS TORT ALERT

For client aggregation assistance, contact (210) 635-0468 or info@masstortamerica.com

Predicted Mass Tort Action:

Qualaquin® (Quinine) malaria treatment

Potential Defendant(s)

• Primary: AR Scientific®/United Research Laboratories (URL) Pharma, Inc.

Primary Defendant Financial Data: $500M – $1B Annual Revenue; Heavily Insured

• Secondary: Prescribing Physicians, Testing Lab, Pharmacies, Hospitals and Other Medical Facilities; financial status varies, mostly insured.

Potential Plaintiffs

Individuals prescribed Qualaquin® for off-label use.

Potential Plaintiff Numerosity

Over 4 million prescriptions written in 2006—Only 1,564 U.S. malaria cases reported to CDC for 2006 (New York Times report).

More than 124,000 people received 300,000 prescriptions in first six months of 2008— Only 1,500 U.S. malaria cases reported to CDC for 2008 (Washington Post report).

Potential Plaintiff Claims

Wrongful Death, Permanent Disability, Life-Threatening Permanent Injury, Medical Malpractice.

Potential Cause of Action

Quinine has been shown to cause death and permanent injury.

Defendants may have facilitated and promoted long-term, off-label prescription and use of Qualaquin®.

Aggravating Circumstance: These actions may have been aggravated by the continued facilitation and promotion of off-label use after repeated FDA warnings over several years from the FDA that such prescribing and use has been linked to deaths, as well as other serious medical conditions including permanent kidney damage, hospitalization, and other life-threatening hematological (serious bleeding) conditions. According to the FDA: A recent report notes that, from January 2006 to June 2008, a large proportion of quinine prescriptions (62%) were written for musculoskeletal symptoms, rather than uncomplicated malaria. “Despite these actions, FDA continues to receive reports of serious adverse events with the use of quinine, most citing off-label use.”

Client Origination and Aggregation Challenges

Most of the potential plaintiffs injured by off-label prescription use of Qualaquin® may not be aware that Qualaquin® has caused their injury or the death of their loved one. The issue has yet to be widely published in the media and the prescribing physicians are unlikely to inform the injured patients or patient’s family that the prescription they wrote caused the injury or death. *Contact us to discuss our client aggregation services (210) 635-0468 info@masstortamerica.com.

Opportunity

The opportunity to be the originator of a mass or class action exists in this issue. Premedia exposure knowledge of these circumstances presents a unique opportunity for a plaintiff law firm. *Contact us to discuss our client aggregation services (210) 635-0468 info@masstortamerica.com.

Client Generation Strategy

Internet search engine domination followed by mass press release. This two-pronged strategy should be sufficient to aggregate a significant number of plaintiffs. Other forms of advertising including television could be indicated if justified by the plaintiff volume acquired in the initial plaintiff aggregation phase. *Contact us to discuss our client aggregation services (210) 635-0468 info@masstortamerica.com.

Disclaimer

If you are not an Attorney this information is not intended for you. If you need legal help, please seek the advice of an Attorney. If you need medical help, please seek the advice of a Medical Doctor. No one should discontinue the use of any medication without seeking the advice of a Medical Doctor. The information provided in this alert is not intended to be legal advice. This alert is provided directly to practicing attorneys and is for the sole use of those attorneys. Further dissemination of this alert is prohibited. It is assumed that the receiving attorney has the ability to conduct independent research on the information provided and does not need to rely solely on the provided information for any purpose. Qualaquin® is a registered trademark of AR Scientific, Inc. Mass Tort America is not affiliated with Qualaquin® or AR Scientific, Inc.

References

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm218424.htm

http://www.fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ucm167883.htm

http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM218269.pdf

http://www.washingtonpost.com/wp-dyn/content/article/2010/03/01/AR2010030102881.html

http://lawprofessors.typepad.com/mass_tort_litigation/2006/12/fda_stopping_sa.html

http://www.qualaquin.com/

http://www.urlpharma.com/url_brand_AR_Scientific.aspx

http://www.annals.org/content/135/12/S65.full

Qualaquin Side Effects

Qualaquin Side Effects – If you are a law firm working with victims of Qualaquin and would like to add content to this website, please email us at leads@masstortamerica.com or you can use the contact form on this page. Qualaquin Lawyers are needed to protect the rights of the victims of Qualaquin.

This blog is intended to bring information to the public about Qualaquin and to help individuals get information from a Qualaquin Lawyer. Our primary focus will be to address how those effected by Qualaquin can seek to recover from the devastation Qualaquin inflicted in their lives. Although no amount of financial recovery may suffice to return what has been lost to the people affected by this drug, they none the less deserve to be financially compensated. Information presented on http://www.qualaquinsideeffects.com is not intended as legal advice. If you are in need of legal advice you should contact an attorney immediately. Many Qualaquin Lawyers provide free consultations.

If you are a law firm working with victims of Qualaquin and would like to add content to this website, please email us at leads@masstortamerica.com or use our contact form.